CPC
NVO

Cookson Peirce & Co’s Novo Nordisk NVO Stock Holding History

Cookson Peirce & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,000
Closed -$208K – 308
2025
Q1 		$208K Buy
+3,000
New +$248K 0.01% 260
2024
Q4 		– Sell
-3,036
Closed -$361K – 293
2024
Q3 		$361K Sell
3,036
-34
-1% -$4.53K 0.02% 218
2024
Q2 		$438K Sell
3,070
-100
-3% -$13.3K 0.02% 180
2024
Q1 		$407K Hold
3,170
– – 0.02% 177
2023
Q4 		$328K Hold
3,170
– – 0.02% 174
2023
Q3 		$288K Hold
3,170
– – 0.02% 181
2023
Q2 		$257K Buy
+3,170
New +$259K 0.02% 185

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cookson Peirce & Co's NVO Position: Q2 2025 in Review

Cookson Peirce & Co sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 3,000 shares — an estimated $208K sold.

Cookson Peirce & Co first reported a position in NVO in Q2 2023 and held it in 7 quarters. The position peaked at $438K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • Cookson Peirce & Co reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,000 Novo Nordisk shares in Q2 2025, an estimated $208K.
  • Cookson Peirce & Co first reported a position in Novo Nordisk in Q2 2023 and held it in 7 quarters.
  • Cookson Peirce & Co's Novo Nordisk position peaked at $438K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Cookson Peirce & Co's 13F filing for Q2 2025, filed 30 Jul 2025.